CLAFORAN

This brand name is authorized in Brazil, Cyprus, Hong Kong SAR China, Ireland, Japan, Mexico, Singapore, Turkey.

Active ingredients

The drug CLAFORAN contains one active pharmaceutical ingredient (API):

1	Cefotaxime UNII 258J72S7TZ - CEFOTAXIME SODIUM
	Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis.
	Read more about Cefotaxime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD01	Cefotaxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502802602159314
HK	Department of Health Drug Office	14614
JP	医薬品医療機器総合機構	6132409D1050, 6132409D2056
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	239M80
SG	Health Sciences Authority	01473P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809271203, 8699809271210, 8699809271227, 8699809271234, 8699809271241